Abstract:The negative regulators in the interferon (IFN) signaling pathway inhibit intrahepatic immune response, resulting in suboptimal therapeutic response to IFN alpha treatment in chronic hepatitis B (CHB) patients. Identifying the key negative factors and elucidating the regulating mechanism are essential for improving anti-HBV (hepatitis B virus) efficacy of IFN alpha. From the Gene Expression Omnibus (GEO) database, we downloaded and analyzed gene expression profiles of CHB patients with different responses to IFN alpha (GSE54747), and found that innate immune status was associated with the IFN alpha-based therapeutic response in CHB patients. Through PCR array, we found higher baseline level of IFN-induced transmembrane protein 2 (IFITM2) mRNA and lower baseline level of IFN alpha mRNA in peripheral blood mononuclear cells (PBMCs) of CHB patients with suboptimal response to IFN alpha treatment. Increased IFITM2 protein was also found in the serum of IFN alpha nonresponsive patients. With further experiments, we found that overexpressing IFITM2 in Huh7 cells suppressed endogenous IFN alpha synthesis by inhibiting phosphorylation of extracellular signal-regulated kinase (ERK), TANK-binding kinase 1 (TBK1), and interferon regulatory factor 3 (IRF3); knocking out IFITM2 enhanced activation of the endogenous IFN alpha synthesis pathway, exhibiting better inhibition on HBV replication. We also found that IFITM2 protein was shuttled by exosomes to dendritic cells (DCs), the main source of endogenous IFN alpha. Exosome-mediated transport of IFITM2 inhibited synthesis of endogenous IFN alpha in DCs whereas the inhibitory effect was abolished when IFITM2 was knocked out. Furthermore, we demonstrated that both palmitoylation inhibitor and mutation on 70/71 sites of IFITM2 protein influenced its incorporation into exosomes. Mutated IFITM2 protein increased the effect of IFN alpha against HBV. Conclusion: Exosome-mediated transport of IFITM2 to DCs inhibits IFN alpha pathway activation and blocks anti-HBV efficacy of exogenous IFN alpha. The findings provide an explanation to the suboptimal response of CHB patients to IFN alpha treatment.

Human Hepatitis B Virus Core Protein Inhibits IFNα-Induced IFITM1 Expression by Interacting with BAF200.

Inhibition of Hepatitis B Virus Gene Expression and Replication by Hepatocyte Nuclear Factor 6

Type III interferon-induced CBFβ inhibits HBV replication by hijacking HBx

Hepatitis B Virus Polymerase Inhibits Rig-I- And Toll-Like Receptor 3-Mediated Beta Interferon Induction In Human Hepatocytes Through Interference With Interferon Regulatory Factor 3 Activation And Dampening Of The Interaction Between Tbk1/Ikk Epsilon And Ddx3

Interferon-Induced Proteins with Tetratricopeptide Repeats 1 and 2 Are Cellular Factors That Limit Hepatitis B Virus Replication

Hepatitis B Virus Regulatory Hbx Protein Binds to Adaptor Protein Ips-1 and Inhibits the Activation of Beta Interferon

Exosomal Interferon-Induced Transmembrane Protein 2 Transmitted to Dendritic Cells Inhibits Interferon Alpha Pathway Activation and Blocks Anti-Hepatitis B Virus Efficacy of Exogenous Interferon Alpha.

The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein

The Functional and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene Expression

Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action

Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKϵ and DDX3

Hepatitis B Virus X Protein Suppresses Virus-Triggered IRF3 Activation and IFN-β Induction by Disrupting the VISA-associated Complex

IFN-α inhibits HBV transcription and replication by promoting HDAC3-mediated de-2-hydroxyisobutyrylation of histone H4K8 on HBV cccDNA minichromosome in liver

Mitochondrial HIGD1A Inhibits Hepatitis B Virus Transcription and Replication Through the Cellular PNKD-NF-B-NR2F1 Nexus

Hepatitis B Virus Polymerase Inhibits the Interferon-Inducible MyD88 Promoter by Blocking Nuclear Translocation of Stat1

Hepatitis B virus X protein is capable of down-regulating protein level of host antiviral protein APOBEC3G

RNA Helicase DDX5 in Association With IFI16 and the Polycomb Repressive Complex 2 Silences Transcription of the Hepatitis B Virus by Interferon

Hepatocyte nuclear factor 1α downregulates HBV gene expression and replication by activating the NF-κB signaling pathway

Mitochondrial HIGD1A inhibits hepatitis B virus transcription and replication through the cellular PNKD‐NF‐κB‐NR2F1 nexus

Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction

Interferon-Inducible Myd88 Protein Inhibits Hepatitis B Virus Replication